A Year with COVID-19: Scientific Engagements Pulse Check
This paper describes survey results from Amgen JAPAC Medical Affairs examining the current state in early 2021 of medical engagement amongst healthcare professionals.
This paper describes survey results from Amgen JAPAC Medical Affairs examining the current state in early 2021 of medical engagement amongst healthcare professionals.
Demonstrate the use of technology to automate part of the MLR Review and Approval process and learn how to provide details of a proof-of-concept to test AI-enabled technology in Medical Affairs.
Here we explore how some of the top Medical Affairs leaders from Johnson & Johnson think about career leadership development opportunities and challenges.
This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.
This webinar helps viewers evaluate theuse, structure and evolution of scientific communications platforms
Unleashing opportunities for better understanding and collaboration between experts in AI and medical
“If you ask patient communities their major concerns, it’s affordable access,” says Alissa Heizler-Mendoza speaking about patient advocacy in Medical Affairs.
MedInfo Teams contribute to the business with clinical expertise, extensive knowledge of the company products and medical literature, insights of customer needs, and a strong understanding of the business.
In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.
The webinar will provide a snapshot of insights on what matters to patients and how pharma fares in terms of patient centricity based on a new patient centricity benchmarking survey piloted in 2019.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.